Cargando…

156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu

BACKGROUND: In the Post Antibiotic era with the ongoing Silent pandemic of AMR, early detection of the resistant gene exhibited by the offending pathogen causing the ailment is of paramount importance. Early diagnosis and formulating the choice of antibiotics in treatment of Multi drug and Pan drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakesh, Gerard J, rohit, anusha, Kumar Dorairajan, Suresh, prasanthi, jaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678023/
http://dx.doi.org/10.1093/ofid/ofad500.229
_version_ 1785150267600142336
author Rakesh, Gerard J
rohit, anusha
Kumar Dorairajan, Suresh
prasanthi, jaya
author_facet Rakesh, Gerard J
rohit, anusha
Kumar Dorairajan, Suresh
prasanthi, jaya
author_sort Rakesh, Gerard J
collection PubMed
description BACKGROUND: In the Post Antibiotic era with the ongoing Silent pandemic of AMR, early detection of the resistant gene exhibited by the offending pathogen causing the ailment is of paramount importance. Early diagnosis and formulating the choice of antibiotics in treatment of Multi drug and Pan drug resistant bacteria helps in reducing the hospital stay and the overall outcome of the patients. Carbapenems serve as the first line drugs for the treatment of drug resistant Gram-negative bacilli (GNB) infections.However, carbapenem resistance (CR) among GNB is quite common in India.CR can be due to carbapenemase production.The most common carbapenemases are bla (KPC), bla(NDM), bla(VIM), bla(IMP-1), and bla(OXA-4.)The present study aims to find the prevalence of Carbapenem resistance thereby aiding in initiating the empirical therapy. By studying the resistance patterns we would be able to know whether the isolate expresses single carbapenemase or multiple carbapenemases which has direct influence in the choice of antimicrobials and patient outcomes. METHODS: A total of One hundred and seventy seven clinical isolates which were Carbapenem non-susceptible Enterobacteriales, Pseudomonas aeruginosa, Acinetobater baumanii and Stenotrophomonas maltophilia isolated during the period of Jan2022- April 2023 (15 months) were included in the study. Carbapenem resistance was confirmed by Vitek 2 automated AST system.These isolates were further subjected to X-pert Carba -R Real Time Multiplex PCR Assay to detect the type of carbapenamses expressed RESULTS: Out of one hundred and seventy seven clinical isolates, one hundred and eight isolates did not produce carbapenemases by X-pert Carba -R Real Time Multiplex PCR Assay. A total of sixty nine isolates(38%) were positve for carbapenemases. Among the sixty nine isolates, thirty isolates(43%) produced bla(NDM,) fourteen isolates(20%) produced bla(OXA-4).One isolate produced bla(IMP-1).Twenty four isolates produced both bla(NDM) and bla(OXA-4.) CONCLUSION: In Madras Medical Mission , New Delhi Metallo-Betalactamase -1 is the most common carbapenemase produced by the clinical isolates from Cardio-Vascular patients.Second most common carbapenemase is OXA-48. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678023
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106780232023-11-27 156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu Rakesh, Gerard J rohit, anusha Kumar Dorairajan, Suresh prasanthi, jaya Open Forum Infect Dis Abstract BACKGROUND: In the Post Antibiotic era with the ongoing Silent pandemic of AMR, early detection of the resistant gene exhibited by the offending pathogen causing the ailment is of paramount importance. Early diagnosis and formulating the choice of antibiotics in treatment of Multi drug and Pan drug resistant bacteria helps in reducing the hospital stay and the overall outcome of the patients. Carbapenems serve as the first line drugs for the treatment of drug resistant Gram-negative bacilli (GNB) infections.However, carbapenem resistance (CR) among GNB is quite common in India.CR can be due to carbapenemase production.The most common carbapenemases are bla (KPC), bla(NDM), bla(VIM), bla(IMP-1), and bla(OXA-4.)The present study aims to find the prevalence of Carbapenem resistance thereby aiding in initiating the empirical therapy. By studying the resistance patterns we would be able to know whether the isolate expresses single carbapenemase or multiple carbapenemases which has direct influence in the choice of antimicrobials and patient outcomes. METHODS: A total of One hundred and seventy seven clinical isolates which were Carbapenem non-susceptible Enterobacteriales, Pseudomonas aeruginosa, Acinetobater baumanii and Stenotrophomonas maltophilia isolated during the period of Jan2022- April 2023 (15 months) were included in the study. Carbapenem resistance was confirmed by Vitek 2 automated AST system.These isolates were further subjected to X-pert Carba -R Real Time Multiplex PCR Assay to detect the type of carbapenamses expressed RESULTS: Out of one hundred and seventy seven clinical isolates, one hundred and eight isolates did not produce carbapenemases by X-pert Carba -R Real Time Multiplex PCR Assay. A total of sixty nine isolates(38%) were positve for carbapenemases. Among the sixty nine isolates, thirty isolates(43%) produced bla(NDM,) fourteen isolates(20%) produced bla(OXA-4).One isolate produced bla(IMP-1).Twenty four isolates produced both bla(NDM) and bla(OXA-4.) CONCLUSION: In Madras Medical Mission , New Delhi Metallo-Betalactamase -1 is the most common carbapenemase produced by the clinical isolates from Cardio-Vascular patients.Second most common carbapenemase is OXA-48. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678023/ http://dx.doi.org/10.1093/ofid/ofad500.229 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Rakesh, Gerard J
rohit, anusha
Kumar Dorairajan, Suresh
prasanthi, jaya
156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu
title 156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu
title_full 156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu
title_fullStr 156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu
title_full_unstemmed 156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu
title_short 156. Prevalence of Carbapenem Resistance Among The Clinical Isolates From Patients With Cardio Vascular Diseases Using X-pert Carba -R Real Time Multiplex PCR Assay in a Tertiary Care Hospital In Tamilnadu
title_sort 156. prevalence of carbapenem resistance among the clinical isolates from patients with cardio vascular diseases using x-pert carba -r real time multiplex pcr assay in a tertiary care hospital in tamilnadu
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678023/
http://dx.doi.org/10.1093/ofid/ofad500.229
work_keys_str_mv AT rakeshgerardj 156prevalenceofcarbapenemresistanceamongtheclinicalisolatesfrompatientswithcardiovasculardiseasesusingxpertcarbarrealtimemultiplexpcrassayinatertiarycarehospitalintamilnadu
AT rohitanusha 156prevalenceofcarbapenemresistanceamongtheclinicalisolatesfrompatientswithcardiovasculardiseasesusingxpertcarbarrealtimemultiplexpcrassayinatertiarycarehospitalintamilnadu
AT kumardorairajansuresh 156prevalenceofcarbapenemresistanceamongtheclinicalisolatesfrompatientswithcardiovasculardiseasesusingxpertcarbarrealtimemultiplexpcrassayinatertiarycarehospitalintamilnadu
AT prasanthijaya 156prevalenceofcarbapenemresistanceamongtheclinicalisolatesfrompatientswithcardiovasculardiseasesusingxpertcarbarrealtimemultiplexpcrassayinatertiarycarehospitalintamilnadu